Chain Bridge I to merge with Phytanix Bio at $58M equity value, ticker to become PHYX

Chain Bridge I

Business Combination Agreement signed July 22, 2024; closing expected Q4 2024.
Equity value of $58 million; HoldCo to issue Series A convertible preferred stock and exchange debt.
HoldCo (New Phytanix) will list on Nasdaq under ticker PHYX after closing.
Conditional on $100M equity line of credit with Keystone Capital Partners and $5M+ net tangible assets.
Lock-up period for sponsor and certain stockholders: 365 days after close (6 months for independent directors).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.